By measuring the tumor volume, we found that GATA3 silencing significantly promoted transplanted CRC tumor growth, while overexpression of GATA3 had no significant effect on tumor growth (Fig. 6a–d), however, Oxa inhibited the tumor-promoting effect of GATA3-shRNA (Fig. 6a–d). This evidence concerns the gene GATA3 and colorectal carcinoma.